viernes, 27 de marzo de 2009

diabetes:

Diabetes News

1 Scientists Closer to Understanding How to Control High Blood Sugar
2 FDA: Insulin Pens and Insulin Cartridges Must Not Be Shared
3 Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Interventions for Multivessel Disease
4 Predicting Risk of Type 2 Diabetes in England and Wales: Prospective Derivation and Validation of QDScore
5 Atrial Fibrillation Predicts Poor Outcome in Diabetes
6 Diagnosis and Prevalence of Onychomycosis in [Neuropathic Patients With Diabetes]

Joint Statement from ADA and AACE on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control In Critically Ill Patients

A study published online March 24th in the New England Journal of Medicine suggests that intensive blood glucose (sugar) control for critical care patients with hyperglycemia (high blood glucose) does not improve outcomes and is associated with an increase in deaths.

The American Diabetes Association (ADA) and the American Association of Clinical Endocrinologists (AACE) maintain that the findings of the Normoglycemia in Intensive Care Evaluation-Survival Using Glucose Algorithm Regulation (NICE-SUGAR) study should NOT lead to an abandonment of the concept of good glucose management in the hospital setting. Uncontrolled high blood glucose can lead to serious problems for hospitalized patients, such as dehydration and increased propensity to infection.
Learn More >>

Upcoming Meetings

24th Annual Southern Regional Conference
May 21-24, 2009
Omni Orlando at ChampionsGate (Orlando), Florida
24th Annual Southern Regional Conference
Registration Information


69th Scientific Sessions
June 5-9, 2009
Morial Convention Center
New Orleans, Louisiana

69th Scientific Sessions Web site
Advance Program
Pre-Register (Deadline: April 23, 2009)
Request Housing (Deadline: May 8, 2009)

Late Breaking Abstract Submission
Abstracts should describe a cutting edge and timely research advance that has not been previously submitted.
Abstract Submission Information (Deadline: 5:00 p.m. EST, Friday, April 3, 2009)

Sign up for the free ADA Scientific Sessions eNewsletter for meeting updates



57th Annual Advanced Postgraduate Course
February 7-10, 2010
San Francisco, California

Annual Postgraduate Course Web site
Webcasts from 56th Annual Postgraduate Course

Resources Online


Diabetes PHD: Free Risk Assessment Tool

Diabetes PHD is an individualhealth risk assessment tool based on the revolutionary Archimedes model of human physiology. The mathematical model underlyingDiabetes PHD program is highly complex, requiring a grid of computers to calculate each health risk profile. The ADA recently created a new dedicated grid of computers to support Diabetes PHD, which hasincreased the number of profiles that can be supported at one time. Many health care professionals have found that the risk profiles generated by Diabetes PHD can have a profound impact in promoting behavior change in their patients.
Try it today!

Continuing Education Opportunities


The American Diabetes Association conducts professional education activities in support of our overall mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. It is our belief that the quality of treatment received by the person with diabetes is directly dependent upon the education and expertise of his or her health care team. You probably know about ADA's local and national meetings, but did you know we also offer on-line continuing education activities on DiabetesPro? Current offerings include highlights of the 68th ADA Scientific Sessions held in June, 2008; Understanding Cardiometabolic Risk; a self-assessment module on basic principles of management of type 2 diabetes; and others.
Continuing Education Library on DiabetesPro

Incretin Mimetics and Their Future in the Treatment of Diabetes

Incretin Mimetics and Their Future in the Treatment of Diabetes is a series of continuing education webcasts which were captured at the American Diabetes Association's 68th Scientific Sessions held on June 6-10, 2008 in San Francisco, California. Each webcast provides insight to clinicians and investigators about incretin mimetics as an emerging treatment. These activities are designed to improve care of the patient with diabetes by providing members of the health care team with an educational program enhancing their knowledge, advancing their skills, and apprising them of the latest research development. The webcasts are available online, free-of-charge to registered participants.
Information and Registration


Other Opportunities


Manpei Suzuki International Prize for Diabetes Research

The Manpei Suzuki Diabetes Foundation is pleased to announce the second year of opening nominations for the Manpei Suzuki International Prize for original and excellent achievements in Diabetes Research. The prize was established in 2008, to commemorate the 15th anniversary of the foundation. By providing this opportunity to researchers of the world, the foundation hopes to advance diabetes research that will contribute to the health and welfare of all people.
Learn More >>

Certificate of Distinction for Inpatient Diabetes Care

The Joint Commission, in collaboration with the American Diabetes Association, has developed a Certificate of Distinction that recognizes hospitals that make exceptional efforts to identify, monitor, and foster better outcomes for hospitalized diabetes patients. Key components recognized by certification include staff education, written blood glucose monitoring protocols, protocols for prevention and treatment of hypo-and hyperglycemia, patient education, and data collection/quality improvement activities.

Contact The Joint Commission for more information on how your hospital can become certified.

Incretin

Subscription Management Center

This eNewsletter is a service of the American Diabetes Association. Some of the articles in Diabetes World are generated from wire service stories only and not by the American Diabetes Association.

To ensure proper delivery of this eNewsletter to your inbox and to enable images to load in future mailings, please add news@diabetes.org to your e-mail address book or safe senders list.

In addition to Diabetes World, we also offer no charge subscriptions to our eNewsletters on topics such as Book News, Advocacy, Volunteering, and Parents of Children with Diabetes.

Should you no longer wish to receive these messages, need to change your email addesss or want to view our available eNewsletter subscriptions, please select from the options below:

View all available eNewsletters
Unsubscribe
Change your Email Address

You are receiving this email at mq@unconformity.com.

The American Diabetes Association is committed to your privacy and we will not make your email address available to any third party.

To view our Privacy Policy click here.

American Diabetes Association
1701 North Beauregard Street
Alexandria, VA 22311
Toll Free: 1-800-342-2383


CONSULTEN, OPINEN , ESCRIBAN LIBREMENTE
Saludos
Rodrigo González Fernández
Diplomado en RSE de la ONU
www.consultajuridicachile.blogspot.com
www.el-observatorio-politico.blogspot.com
www.lobbyingchile.blogspot.com
www.biocombustibles.blogspot.com
www.calentamientoglobalchile.blogspot.com
oficina: Renato Sánchez 3586 of. 10
Teléfono: OF .02-  8854223- CEL: 76850061
e-mail: rogofe47@mi.cl
Santiago- Chile
Soliciten nuestros cursos de capacitación  y consultoría en LIDERAZGO -  RESPONSABILIDAD SOCIAL EMPRESARIAL – LOBBY – BIOCOMBUSTIBLES  ,   y asesorías a nivel internacional y están disponibles  para OTEC Y OTIC en Chile